Regulatory Requirements for Investigational Drugs - à¸à¸£à¸°à¸à¸£à¸§à¸à¸ªà¸²à¸à¸²à¸£à¸à¸ªà¸¸à¸
Regulatory Requirements for Investigational Drugs - à¸à¸£à¸°à¸à¸£à¸§à¸à¸ªà¸²à¸à¸²à¸£à¸à¸ªà¸¸à¸
Regulatory Requirements for Investigational Drugs - à¸à¸£à¸°à¸à¸£à¸§à¸à¸ªà¸²à¸à¸²à¸£à¸à¸ªà¸¸à¸
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Thailand<br />
Food &<br />
Drug<br />
Administration<br />
PILOTING OF THE IND-LIKE PROCESS :<br />
ตัวอย่าง การพัฒนา Pandemic Live Attenuated Influenza vaccine<br />
(PLAIV) (H1N1) By Local manufacturer<br />
• Pre IND Meeting between NRA and sponsor/manufacturer<br />
– Product description/product characteristic<br />
– Preclinical data<br />
• IND Meeting Prior to Phase I-II :<br />
– Pre-clinic and Clinical lot production<br />
– Clinical Trial Protocol Development (objectives, design,<br />
number of subject, schedule)<br />
• Dossier <strong>for</strong> registration MA